US20080154303A1 - Hemostasis-enhancing device and method for its use - Google Patents
Hemostasis-enhancing device and method for its use Download PDFInfo
- Publication number
- US20080154303A1 US20080154303A1 US11/614,276 US61427606A US2008154303A1 US 20080154303 A1 US20080154303 A1 US 20080154303A1 US 61427606 A US61427606 A US 61427606A US 2008154303 A1 US2008154303 A1 US 2008154303A1
- Authority
- US
- United States
- Prior art keywords
- expansible member
- another
- catheter
- expansible
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
- A61M5/16881—Regulating valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
- A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/0061—Implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00676—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect promotion of self-sealing of the puncture
Definitions
- the present invention relates generally to devices, systems, and methods for percutaneous sealing of puncture sites in body lumens or tissue tracts. More specifically, the present invention relates to devices, systems, and methods for use in hemostasis of vascular puncture sites.
- Percutaneous access of blood vessels in the human body is routinely performed for diagnostics or interventional procedures such as coronary and peripheral angiography, angioplasty, atherectomies, placement of vascular stents, coronary retroperfusion and retroinfusion, cerebral angiograms, treatment of strokes, cerebral aneurysms, and the like.
- diagnostics or interventional procedures such as coronary and peripheral angiography, angioplasty, atherectomies, placement of vascular stents, coronary retroperfusion and retroinfusion, cerebral angiograms, treatment of strokes, cerebral aneurysms, and the like.
- Patients undergoing these procedures are often treated with anti-coagulants such as heparin, thrombolytics, and the like, which make the closure and hemostasis process of the puncture site in the vessel wall at the completion of such catheterization procedures more difficult to achieve.
- the present invention advantageously provides devices, assemblies, and methods for percutaneous access and closure of puncture sites in a body lumen, particularly blood vessels of the human body. It will be appreciated however that application of the present invention is not limited to the blood vasculature, and as such may be applied to any of the vessels, even severely tortuous vessels, ducts, and cavities found in the body as well as tissue tracts. Such closure devices, systems, and methods utilize the body's own natural healing mechanism to achieve complete hemostasis without leaving any foreign objects behind.
- the device for enhancing the hemostasis of a puncture site in a body lumen or tract comprises a catheter having one tubular member having a proximal end and a distal end with one inner lumen extending along at least a longitudinal portion of the catheter tubular member.
- the one tubular member includes external and internal tubular bodies each having proximal and distal ends. At least one of the external and the internal tubular bodies is longitudinally movable with respect to the other.
- An expansible member with proximal and distal ends is disposed on the distal end of the one tubular member. The distal end of the expansible member is attached to the distal end of internal tubular body, while the proximal end of the expansible member is attached to the distal end of external tubular body.
- the expansible member is expanded by the longitudinal movement of the internal and external tubular bodies with respect to one another.
- the expansion is achieved by maintaining the internal tubular body in position while moving the external tubular body distally with respect to the internal tubular body.
- the degree of expansion of the expansible member in an embodiment is based on the longitudinal displacement between the external and the internal tubular bodies.
- the expansible member comprises a mesh layer, spring, coil, slotted tube, coiled string, or braided filament such as one with small pores.
- distal and proximal spacers are disposed at the distal ends of the external and internal tubular bodies, connecting the external and the internal tubular bodies with the proximal and the distal ends of the expansible members; respectively.
- the outer diameter of the expansible member at the distal and proximal ends may be similar or different (e.g., greater or smaller).
- the difference between the outer diameter of the expansible member at its proximal and distal ends affects the direction of the movement of the expansible member upon its expansion.
- when the outer diameter at the distal end is less than that at the proximal end, it enables the expansible member to fold forward (in the distal direction) upon expansion.
- the change in the outer diameter at the distal end of the expansible member may be achieved by providing a distal spacer having a smaller thickness than the proximal spacer, or removing the distal spacer in total.
- the internal tubular body of the one catheter is configured for fluid communication; at its distal end with the body lumen; and at its proximal end with a mechanism for removal of bodily fluids, such as blood, from the body.
- the fluid body removal mechanism may be a syringe or syringe/hemostatic valve mechanism as commonly available.
- the one catheter is advanced to the body through a puncture site at the skin, tissue/fascia, and then the body lumen.
- the one expansible member is thereafter expanded intraluminally and seated against a vessel wall.
- the expansible member is expanded by the internal tubular body moving the external tubular body distally relative to the internal tubular body and subsequently placed against the vessel site at the puncture site.
- the expansible member may be allowed to remain in the body lumen until the puncture site has healed, after which the expansible member is collapsed and removed slowly from the human body.
- the optional syringe may be used to withdraw bodily fluids using the lumen of the internal tubular body of the one catheter.
- the one expansible member of the one catheter is advanced to the tissue/fascia, and expanded extraluminally within the fascia along a tissue tract of the puncture site.
- the expansible member is expanded by maintaining the internal tubular body stationary while moving the external tubular body distally and thereafter removed upon achieving the desired effect.
- another catheter having another tubular member with proximal and distal ends and another expansible member with proximal and distal ends disposed on the distal end of the another tubular member is provided.
- the inner diameter of the internal tubular body of the one catheter and the outer diameter of the tubular member of the another catheter are configured such that the another catheter is disposable within the lumen of the internal tubular body of the one catheter.
- the one and the another catheters may be advanced simultaneously or separately within the body.
- the expansible members may be, independently, disposed within the body lumen and the tissue/fascia.
- the expansible members may be expanded simultaneously or sequentially in any order as appropriate.
- the expansible members may be unexpanded and retracted from the body lumen and/or the tissue/fascia as necessary.
- the one and the another catheters are pre-loaded into one another (e.g., the one catheter is disposed over the another catheter) forming a catheter assembly.
- the one and the another catheter may be advanced simultaneously or separately to within the body.
- the expansible members may be, independently, disposed within the body lumen and the tissue/fascia.
- the expansible members may be expanded simultaneously or sequentially in any order as appropriate.
- the expansible members may be unexpanded and retracted from the body lumen and/or the tissue/fascia as necessary.
- either or both of the expansible members may be at least partially covered with a flexible membrane.
- an introducer sheath is disposed through an opening in a skin surface, tissue tract in fascia, and a vessel wall, and is seated in a vessel lumen.
- the one and the another catheter may be introduced alone without the use of the other, or they may be used in conjunction with one another.
- each of the catheters may be introduced together with the other, separately, sequentially, or as an integrated system to the patient's body.
- either or both the one and the another catheter are introduced directly or indirectly through the introducer sheath.
- Either or both the expansible members independently, may be expanded intraluminally or extraluminally within the tissue/fascia.
- a syringe may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internal tubular body.
- the one catheter is introduced through the sheath and the expansible member is advanced into and deployed within the body lumen.
- the introducer sheath is then slowly withdrawn from the body, leaving the one expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen.
- the one catheter including the one expansible member is left in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- the one catheter is introduced through the sheath and the expansible member is a advanced into the body lumen.
- the introducer sheath is then slowly withdrawn from the body, leaving the one catheter and the one expansible member in place.
- the another catheter is then inserted through the proximal end of the one catheter.
- the another expansible member is advanced within the body lumen to a position distal of the one expansible member.
- the expansible members are deployed, simultaneously, or separately (in any order desired).
- the another expansible member is then contracted and the another catheter is pulled proximally and removed from the body through the lumen of the one catheter, leaving the one catheter and the expansible member seating against the vessel wall at the puncture site within the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- the another catheter of an assembly comprising both the one and the another catheters, is preloaded within the lumen of the internal tubular body of the one catheter.
- the distal end of the assembly is then inserted through the sheath and the assembly (including both the one and another catheters) is advanced through an opening in skin, and through tissue tract.
- the another catheter is advanced until the another expansible member is disposed within the body lumen while the one catheter's expansible member is placed at a predetermined distance from the vessel wall within the tissue/fascia.
- the introducer sheath is then slowly pulled proximally and retracted from the body lumen, with the one and another expansible members located in the tissue/fascia and the body lumen, respectively.
- the one and the another expansible members are then expanded in their respective locations, with the one expansible member in the tissue/fascia and the another expansible member seating against the vessel wall at the puncture site within the body lumen.
- the another expansible member is then contracted and the another catheter is then pulled proximally and removed from the body through the lumen of the one catheter, leaving the one catheter and the one expansible member in the tissue fascia as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- the another catheter is preloaded within the lumen of internal tubular body of the one catheter forming the assembly of the two catheters.
- the distal end of the assembly is then inserted through a hub of the sheath, thereby advancing the assembly through an opening in skin, and through the tissue tract, and within the body lumen.
- the one and the another expansible members With the one and the another expansible members positioned within the body lumen and expanded, the one expansible member rests against the vessel wall at the puncture site, while the another expansible member is placed against the distal end of the one expansible member.
- the introducer sheath is then slowly pulled proximally and retracted from the body lumen, leaving the first and second catheters in place within the body lumen.
- the one expansible member is then contracted and the one catheter is then pulled proximally and removed from the body over the another catheter, leaving the another catheter and the another expansible member in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- the another expansible member may be contracted and removed from the body lumen first, leaving the one expansible member in place as long as necessary before withdrawing it from the patient's body.
- the another catheter of the device is inserted through the existing sheath, advancing the another expansible member within the body lumen.
- the another expansible member is then expanded by holding the distal handle part of another catheter handle assembly stationary and moving the proximal handle part proximally.
- the introducer sheath is then slowly pulled proximally and retracted from the body lumen, leaving the another catheter in place with the another expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen.
- the proximal end of the another catheter is pushed through the distal end of the one catheter and fed through the lumen of its internal tubular body until it exists the proximal end of the one catheter.
- the one catheter is then guided over the tubular member of the another catheter through an opening in skin, through tissue tract, until its distal end is placed at a predetermined distance from the vessel wall and against subcutaneous tissue.
- the one expansible member is then expanded over the puncture site of the vessel wall by pulling the handle of the external tubular body proximally while maintaining the internal tubular body of the one catheter substantially stationary.
- the another expansible member is then contracted and the another catheter is then pulled proximally and removed from the body through the lumen of the one catheter, leaving one catheter and the one expansible member in the tissue fascia as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- each of the one expansible member and the another expansible members when used in combination with one another, may, independently, be expanded within the body lumen or within the tissue/fascia.
- FIG. 1A illustrates a device for enhancing the hemostasis of a puncture site in a body lumen or tract embodying features of the present invention and having an expandable member at a distal end.
- FIG. 1B illustrates an alternative design of the device of FIG. 1 having a seal at a proximal end of the device.
- FIG. 1C illustrates an alternative design of the device of FIG. 1 having a detachable syringe at a proximal end of the device for removal of bodily fluids to and from the body lumen.
- FIG. 2 illustrates the device of FIG. 1 showing the expandable member in an expanded position.
- FIGS. 3-5 illustrate exemplary embodiments of the expansible member of the device of FIG. 1 , in expanded configuration.
- FIG. 6 illustrates an assembly for enhancing the hemostasis of a puncture site in a body lumen or tract embodying features of the present invention and including the device of FIG. 1 and another device disposed within the first device.
- FIG. 7 illustrates the device of FIG. 6 showing the expandable members in an expanded position.
- FIGS. 8A though 8 E illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the device of FIG. 1 .
- FIGS. 9A though 9 G illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown in FIG. 6 .
- FIGS. 10A though 10 F illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown in FIG. 6 .
- FIGS. 11A though 11 E illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown in FIG. 6 .
- FIGS. 12A through 12H illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown in FIG. 6 .
- FIGS. 13A through 13G illustrate the method of FIGS. 12A through H, with the devices shown in longitudinal cross sectional views.
- FIGS. 1A through 1C and FIG. 2 illustrate a hemostasis-enhancing device 10 embodying features of the present invention and generally comprising one catheter 13 having one tubular member 16 with proximal and distal ends 19 and 22 , one elongated internal tubular body 25 , and one elongate external tubular body 28 slidably disposed over the internal tubular body 25 .
- the inner and external tubular bodies 25 and 28 each respectively has proximal ends 31 and 34 , distal ends 37 and 40 , and inner lumens 43 and 46 extending between the proximal and distal ends of each body.
- the distal end 40 of the external tubular body 28 is proximally set apart at a longitudinal distance from the distal end 37 of the internal tubular body. It will be appreciated that the above depictions, as shown, are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of the device 10 . This applies to all depictions hereinafter.
- the inner and/or the outer elongate bodies 25 and 28 may be independently chosen to be flexible or rigid.
- the distal end 55 of the one expansible member 49 is sealingly secured to the distal end 37 of the internal tubular body 25 at a distal connection point 61
- the proximal end 52 of the one expansible member is sealingly secured to the distal end 40 of the external tubular body 28 at a proximal connection point 64 ; respectively.
- the proximal and distal ends 52 and 55 of the one expansible member 49 may be separated from the outer and internal tubular bodies 25 and 28 , by way of proximal and distal spacers 67 and 70 ; respectively.
- the connection of the one expansible member 49 with the inner and external tubular bodies may be made with a crimp process, use of shrink tubing such as polyester tubing, adhesives such as glue, heat staking member into member, or a combination thereof.
- a seal 73 may be disposed at the proximal end of the internal tubular body 25 , or any other suitable position along the length thereof.
- the seal may be made of any self-sealing material and may include a cross-cut to enable the insertion and/or withdrawal of other elongate members from the lumen 43 of the internal tubular body 25 .
- the one catheter at the proximal end 19 may be equipped with a suitable connector 79 for attaching a syringe (not shown) or the like to deliver fluids to or from the body lumen.
- the syringe may be used to withdraw bodily fluids, such as blood, from the body lumen during the procedure.
- the one expansible member is shown in expanded configuration with the proximal end 34 of the external tubular body 28 being distally spaced apart from the proximal end 31 of the internal tubular body 25 , causing the radial expansion of the one expansible member 49 .
- the outer diameters 50 and 51 of the one tubular member 16 at the proximal and distal ends 52 and 55 of the expansible member are substantially similar, with the thickness of the distal spacer 70 being greater than that of the proximal spacer 67 .
- the expansible member substantially and uniformly expands upon expansion.
- the outer diameter of the one tubular member 16 at the proximal end 52 of the one expansible member 49 is greater than that at the expansible member distal end 55 .
- the outer diameter of the one tubular member 16 at the proximal end of the expansible member 49 is relatively much greater than that at the expansible member distal end 55 .
- the difference in the outer diameter of the one tubular member 16 at the proximal and distal ends of the expansible member affect the shape of the expansible member upon expansion.
- the smaller outer diameter at the distal end of the expansible member enables the expansible member to fold in the proximal direction upon expansion.
- the proximal and distal spacers may be used to provide the desired outer diameter relationship at the proximal and distal ends of the expansible member.
- the length of the expansible member may configured to provide the desired shape upon expansion (e.g., disc or cylinder).
- a handle assembly 80 may be removably connectable at the proximal end 19 of the one catheter 13 .
- a proximal part 83 of the handle is connectable to the proximal end 31 of the internal tubular body 25 and a distal part 86 is connectable to the proximal end 34 of the external tubular body 28 .
- Handle parts 83 and 86 provide for an enhanced grip on the device 10 , allowing the user to more conveniently move either or both the inner and the external tubular bodies with respect to the other for the purpose of deploying and retracting the expansible member.
- the external tubular body is longitudinally movable while the internal tubular body is maintained substantially stationary.
- the one catheter 13 and its inner and external tubular bodies may be formed from solid or coiled stainless steel tubing or polymer materials such as nylon, polyurethane, polyimide, PEEK®, PEBAX®, and the like.
- the catheter may have a length in a range from about 5 centimeters (“cm”) to about 50 cm, preferably in the range from about 10 cm to about 40 cm; and a diameter in the range from about 0.5 millimeters (“mm”) to about 0.6 mm, preferably in the range from about 1 mm to about 4 mm.
- the inner diameter of the internal tubular body 25 in an embodiment, is sufficiently large to enable housing of another catheter within, as described further below with respect to FIG. 6 .
- the maximum outer diameter of the external tubular body of the one catheter in an embodiment, when the device is used through in dwelling sheath is chosen to be less than the inside diameter of an introducer sheath. For example, when a 5 Fr (French) sheath is used, the maximum diameter of the external tubular body of the one catheter would be less than 1.75 mm. The smaller this difference, the greater the interference between the external tubular body of the one catheter and the sheath.
- the one expansible member 49 in a retracted or unexpanded state has a diameter of less than about 10 mm, preferably less than about 4 mm, as shown in FIG. 1A .
- the one expansible member 49 in an expanded state has a diameter in a range from about 2 mm to about 25 mm, preferably from about 4 mm to about 15 mm, as shown in FIG. 2 (or the other expanded embodiments shown).
- the expanded diameter, as referenced, is measured at the largest nominal external diameter, as for example, at the intermediate portion 58 .
- Exemplary expansible member structures are described in detail in U.S. Pat. No. 5,836,913 and co-pending U.S. patent application Ser. No. 10/718,504, both assigned to the assignee of the present application and incorporated herein by reference in their entirety.
- the expansible member 49 may comprise a variety of structures including a braided filament, mesh layer, spring, coil, slotted tube, or balloon.
- a deformable membrane 90 may be at least partially disposed over the one expansible member 49 .
- the braid may be sufficiently tight such that without the use of a membrane in a deployed state, it can adequately occlude the puncture site in the vessel.
- the expansible member may also be coated with a highly hydrophobic coating such as TEFLON® or HYDRO-SIL®.
- the combination of small pores in the braided mesh and high surface tension of the expansible member achieved by the use of such coatings may provide an adequate barrier to blood flow through the puncture site.
- the expansible member occludes the vascular surface at the puncture site without substantially disturbing the blood flow to the lower extremities.
- the optional membrane 90 may be formed from a variety of medical grade materials, such as thermoplastic elastomers (e.g., CHRONOPRENE® or POLYBLEND®) having durometers in a range from 15A to about 40A.
- Adhesives such as LOCTITE® 4014 may be used to attach the optional membrane to the one catheter tubular body 16 at the proximal and distal connection points, 93 and 96 .
- the membrane may take a form of a sock having its distal end sealed through a heat stake process or the like. In this case, the membrane may not have to be attached distally.
- the optional membrane preferably has a diameter that is sufficient to cover the expansible member.
- the membrane may be designed and attached to facilitate one expansible member expansion as well as to reduce the amount of required elongation and the stretch of the membrane when the expansible member is deployed. This may be achieved by molding the membrane so that its midpoint diameter, where deployed expansible member has its greatest diameter, is larger than its proximal and distal end diameters (e.g., a spherical shape).
- the membrane may also be formed like a tube with a larger diameter than needed (diameter of retracted expansible member), and then stretched over the expansible member and attached. The stretch should be enough to reduce the diameter of the membrane to that of the expansible member. In such a case, when the one expansible member is deployed, there is less elongation and stress experienced by the membrane.
- the membrane may additionally form a membrane tip (not shown) at the distal end of the catheter so as to provide a soft and blunt point for percutaneous access.
- a flexible tip deflector may be coupleable to the catheter body distal the expansible member so as to prevent any damage to the surrounding vessel wall. The use of the membrane is preferred when the expansible member is used for intraluminal expansion within a target site in the body of the patient.
- a hemostasis-enhancing assembly 500 includes the hemostasis-enhancing device 10 , and another device 20 generally comprising another flexible catheter 213 that is slidably disposable within the internal tubular body 25 of the one catheter 13 .
- the another catheter 213 may be removably disposable within the inner lumen of the one catheter or the two catheters may be integrally formed with one another, forming a single catheter assembly 500 .
- the another flexible catheter 213 generally includes another elongate tubular member 216 with proximal and a distal ends 219 and 222 .
- the another catheter 213 may be of any suitable construction as for example, detailed in co-pending U.S. patent application Ser. No. 10/974,008 (Attorney Docket No. 021872-002010US), filed on Oct. 25, 2004; Ser. No. 10/857,177, (Attorney Docket No. 021872-002000US), filed May 27, 2004; Ser. No. 10/821,633, (Attorney Docket No. 021872-001900US), filed on Apr. 9, 2004; the full disclosures of which are incorporated herein by reference in their entirety.
- the another catheter's elongate tubular member 216 may be formed from coiled stainless steel tubing or polymer materials such as nylon, polyurethane, polyimide, PEEK®, PEBAX®, and the like.
- the another elongate tubular member 216 may have a length in a range from about 10 cm to about 50 cm, preferably in the range from about 15 cm to about 30 cm and a diameter in the range from about 0.25 mm to about 5 mm, preferably in the range from about 0.5 mm to about 2 mm.
- Another expansible member 249 is disposed at the distal end 222 of the another elongate member. Exemplary expansible member structures are described in detail in co-pending U.S. patent application Ser. No. 10/974,008 filed on Oct. 25, 2004 (Attorney Docket No. 021872-002010US), assigned to the assignee of the present application and incorporated herein by reference in its entirety.
- the another expansible member 249 in a retracted or unexpanded state has an outer diameter of less than about 5 mm, preferably less than about 3 mm, as shown in FIG. 6 .
- the another expansible member 249 in an expanded state has an outer diameter in a range from about 2 mm to about 25 mm, preferably from about 3 mm to about 10 mm, as shown in FIG. 7 .
- the expanded diameter, as referenced, is measured at the largest nominal external diameter, as for example, at an intermediate portion 258 .
- the another expansible member may similar to the one expansible member, be, at least partially, covered by another optional membrane 290 , as described in reference to the one expansible member, and with independently selected features or characteristics as described above.
- Another handle assembly 280 may be removably connectable at the proximal end 219 of the another elongate member 216 .
- handle parts 283 and 286 provide for an enhanced grip on the device 20 , allowing the user to more conveniently move the another elongate member 216 in and out of the one catheter 10 , as well as deploying and retracting the another expansible member 249 .
- the longitudinal movement of the proximal handle part 283 of the another elongate member 216 will enable the deployment or retraction of the another expansible member 249 .
- the another expansible member 249 may comprise a push or a pull type deployment means as is described in detail in co-pending U.S. patent application Ser. No.
- device 10 alone or in combination with device 20 , as separate devices, or as assembly 500 , are described below. As can be appreciated, many of the details previously described do not necessarily appear in the method figures for purposes of clarity.
- FIGS. 8A through 8E features of an exemplary method for hemostasis of a puncture site in a body lumen employing the device of FIGS. 1A through 1C are illustrated.
- FIG. 8A depicts an existing introducer sheath 400 disposed through an opening in a skin surface 403 , tissue tract in fascia 406 , and vessel wall 409 and seated in a vessel lumen 412 , at the completion of a catheterization procedure.
- the device 10 (e.g., of FIG. 1A ), is then inserted through a hub 415 of the sheath 400 to a marking, such as when the distal end of the distal handle part 86 of the one catheter 10 rests against the hub of the sheath, as shown in FIG. 8B , thereby advancing the one expansible member 49 within the body lumen 412 .
- the one expansible member 49 is then deployed within the body lumen by moving the proximal handle part 83 of the one catheter handle assembly 80 relative to the distal handle part 86 , as described relative to FIGS. 1 and 2 .
- the introducer sheath 400 is then slowly pulled proximally and retracted (not shown) from the body lumen, leaving the one catheter in place with the one expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen.
- the one catheter including the one expansible member 49 is left in body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis ( FIG. 8D ), after which it is removed from the patient's body ( FIG. 8E ).
- the syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internal tubular body 25 .
- FIGS. 9A through 9G features of an exemplary method for hemostasis of a puncture site in a body lumen employing the devices 10 and 20 of FIGS. 6-7 is illustrated.
- FIG. 9A depicts an existing introducer sheath 400 disposed through an opening in a skin surface 403 , tissue tract in fascia 406 , and vessel wall 409 and seated in a vessel lumen 412 , at the completion of a catheterization procedure.
- the device 10 (e.g., of FIG. 1A ), is then inserted through a hub 415 of the sheath 400 to a marking, such as when the distal end of the distal handle part 86 of the one catheter 10 rests against the hub of the sheath, as shown in FIG. 9B , thereby advancing the one expansible member 49 within the body lumen.
- the introducer sheath is then slowly pulled proximally and retracted (not shown) from the body lumen, leaving the one catheter in place ( FIG. 9C ).
- the another catheter 213 of the device 20 is then inserted through the proximal end 19 of the one catheter 13 (e.g., seal 73 of one catheter of FIG. 1B ), thereby advancing the another expansible member 249 distal to the one expansible member and within the body lumen ( FIG. 9D ).
- the expansible members 49 and 249 are then deployed, simultaneously or separately (in any order as desired, as for example first expanding the another expansible member followed by expansion of the one expansible member or vice versa).
- the one catheter 13 and the another catheter 213 are pulled proximally to place the expansible member 49 against the vessel wall and the another expansible member 249 against the distal opening of the one catheter 13 , so that in combination, the two catheters can help achieve sufficient blockage of the puncture site.
- the another expansible member 249 is then contracted and another catheter 213 is then pulled proximally and removed from the body (not shown) through the lumen of the one catheter 13 , leaving the one catheter and the one expansible member seating against ( FIG. 9F ) the vessel wall at the puncture site within the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body ( FIG. 9G ).
- a syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internal tubular body 25 .
- the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- FIGS. 10A through 10F features of an exemplary method for hemostasis of a puncture site in a body lumen employing the assembly 500 comprising devices 10 and 20 of FIGS. 6-7 is illustrated.
- FIG. 10A depicts an existing introducer sheath 400 disposed through an opening in a skin surface 403 , tissue tract in fascia 406 , and vessel wall 409 and seated in a vessel lumen 412 , at the completion of a catheterization procedure.
- the another catheter 213 of the assembly 500 is preloaded within the lumen 43 of the internal tubular body 25 of the one catheter 13 .
- the distal end of the assembly 500 is then inserted through a hub 415 of the sheath 400 , thereby advancing the assembly 500 including both the one and another catheters through an opening in skin 403 , through tissue tract 406 .
- the another catheter 216 is advanced until the another expansible member is disposed within the body lumen 412 while the one catheter's expansible member 49 is placed at a predetermined distance from the vessel wall 409 within the tissue/fascia 406 ( FIG. 10B ).
- the introducer sheath 400 is then slowly pulled proximally and retracted (not shown) from the body lumen, with the one and another expansible members located in the tissue/fascia and the body lumen, respectively ( FIG. 10C ).
- the one and the another expansible members are then expanded in their respective locations, with the one expansible member in the tissue/fascia and the another expansible member seating against the vessel wall at the puncture site within the body lumen.
- the another expansible member 249 is then contracted and the another catheter 213 is then pulled proximally and removed (not shown) from the body through the lumen of the one catheter 13 , leaving one catheter and the one expansible member 49 in the tissue fascia ( FIG. 10E ) as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body ( FIG. 10F ).
- a syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen 43 of the internal tubular body 25 .
- the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- FIGS. 11A through 11E features of a method for hemostasis of a puncture site in a body lumen employing the assembly 500 comprising devices 10 and 11 of FIGS. 6-7 is illustrated.
- FIG. 11A depicts an existing introducer sheath 400 disposed through an opening in a skin surface 403 , tissue tract in fascia 406 , and vessel wall 409 and seated in a vessel lumen 412 , at the completion of a catheterization procedure.
- the another catheter 213 of the assembly 500 is preloaded within the lumen 43 of internal tubular body 25 of the one catheter 13 .
- the distal end of the assembly 500 is then inserted through a hub of the sheath 400 , thereby advancing the assembly 500 including both the one and another catheters through an opening in skin 403 , through tissue tract 409 .
- the one expansible member rests against the vessel wall at the puncture site, while the another expansible member is placed against the distal end of the one expansible member.
- the introducer sheath 400 is then slowly pulled proximally and retracted (not shown) from the body lumen 412 , leaving the first and second catheters in place within the body lumen ( FIG. 11C ).
- the one expansible member 49 is then contracted and the one catheter 13 is then pulled proximally and removed ( FIG. 11D ) from the body over the another catheter 213 , leaving the another catheter and the another expansible member 249 in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body ( FIG. 11E ).
- a syringe (now shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen 43 of the internal tubular body 25 .
- the another expansible member may be contracted and removed from the body lumen first, leaving the one expansible member in place as long as necessary before withdrawing it from the patient's body.
- FIGS. 12A-12H and 13 A- 13 G features of an exemplary method for hemostasis of a puncture site in a body lumen employing the device 10 and 20 of FIGS. 6-7 is illustrated.
- FIGS. 12A and 13A depict an existing introducer sheath 400 disposed through an opening in a skin surface 403 , tissue tract in fascia 406 , and vessel wall 409 and seated in a vessel lumen 412 , at the completion of a catheterization procedure.
- the another catheter 123 of the of device 20 is then inserted through a hub 415 of the sheath 400 to a marking, such as when the distal end of the distal handle part of the another catheter rests against the hub of the sheath, as shown in FIGS. 12B and 13B , thereby advancing the another expansible member 249 within the body lumen 412 .
- the another expansible member 249 is then expanded by holding the distal handle part 286 of another catheter handle assembly stationary and moving the proximal handle part 283 proximally.
- the introducer sheath 400 is then slowly pulled proximally and retracted from the body lumen (not shown), leaving the another catheter in place with the another expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen ( FIGS. 12D and 13D ).
- the proximal end of the another catheter 213 is pushed through the distal end of the one catheter 13 and fed through the lumen of its internal tubular body until it exits the proximal end of the one catheter.
- the one catheter is then guided over the tubular member of the another catheter through an opening in skin, through tissue tract, until its distal end is placed at a predetermined distance from the vessel wall and against subcutaneous tissue.
- the one expansible member is then expanded over the puncture site of the vessel wall by pulling the handle of the external tubular body proximally while maintaining the internal tubular body of the one catheter substantially stationary ( FIGS. 12F and 13F ).
- the another expansible member 249 is then contracted and the another catheter 123 is then pulled proximally and removed (not shown) from the body through the lumen of the one catheter, leaving the one catheter and the one expansible member in the tissue fascia ( FIGS. 12G and 13G ) as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body ( FIG. 12H ).
- the syringe as for example shown in FIG. 1C , may be used to draw bodily fluids, such as blood, from the body through the lumen of the internal tubular body.
- each of the one expansible member and the another expansible members when used in combination with one another, may, independently, be expanded within the body lumen or within the tissue/fascia.
Abstract
Description
- The present application is related to U.S. patent application Ser. No. 10/974,008 (Attorney Docket No. 021872-002010US), filed on Oct. 25, 2004; Ser. No. 10/857,177 (Attorney Docket No. 021872-002000US), filed May 27, 2004; Ser. No. 10/821,633 (Attorney Docket No. 021872-001900US), filed on Apr. 9, 2004; the full disclosures of which are incorporated herein by reference in their entirety.
- 1. Field of the Invention
- The present invention relates generally to devices, systems, and methods for percutaneous sealing of puncture sites in body lumens or tissue tracts. More specifically, the present invention relates to devices, systems, and methods for use in hemostasis of vascular puncture sites.
- Percutaneous access of blood vessels in the human body is routinely performed for diagnostics or interventional procedures such as coronary and peripheral angiography, angioplasty, atherectomies, placement of vascular stents, coronary retroperfusion and retroinfusion, cerebral angiograms, treatment of strokes, cerebral aneurysms, and the like. Patients undergoing these procedures are often treated with anti-coagulants such as heparin, thrombolytics, and the like, which make the closure and hemostasis process of the puncture site in the vessel wall at the completion of such catheterization procedures more difficult to achieve.
- Various devices have been introduced to provide hemostasis, however none have been entirely successful. Some devices utilize collagen or other biological plugs to seal the puncture site. Alternatively, sutures and/or staples have also been applied to close the puncture site. External foreign objects such as plugs, sutures, or staples however may cause tissue reaction, inflammation, and/or infection as they all “leave something behind” to achieve hemostasis.
- There is also another class of devices that use the body's own natural mechanism to achieve hemostasis wherein no foreign objects are left behind. Such devices typically provide hemostasis by sealing the puncture site from the inside of the vessel wall wherein the device is left in place in the vessel lumen until hemostasis is reached and thereafter removed. Although such devices have achieved relative levels of success, removal of the device at times may disrupt the coagulant that is formed at the puncture site. This in turn may cause residual bleeding which requires the device user to apply a few minutes of external manual pressure at the puncture site after the removal of the device to achieve complete hemostasis.
- It would be desirable to provide alternative devices, systems, and methods to enhance the hemostasis of a puncture site in a body lumen, particularly blood vessels of the human body. At least some of the these needs are met by the devices, systems, and methods of the present invention described hereinafter.
- 2. Related Applications
- Hemostasis devices for use in blood vessels and tracts in the body are described in co-pending U.S. patent application Ser. Nos. 10/974,008; 10/857,177; 10/821,633; and 10/718,504; and U.S. Pat. Nos. 6,656,207; 6,464,712; 6,056,770; 6,056,769; 5,922,009; and 5,782, 860, assigned to the assignee of the present application. The following U.S. patents and Publications may be relevant to the present invention: U.S. Pat. Nos. 4,744,364; 4,852,568; 4,890,612; 5,108,421; 5,171,259; 5,258,000; 5,383,896; 5,419,765; 5,454,833; 5,626,601; 5,630,833; 5,634,936; 5,728,134; 5,836,913; 5,861,003; 5,868,778; 5,951,583; 5,957,952; 6,017,359; 6,048,358; 6,296,657; U.S. Publication Nos. 2002/0133123; 2003/0055454; and 2003/0120291.
- The full disclosure of each of the above mentioned references is incorporated herein by reference in its entirety.
- The present invention advantageously provides devices, assemblies, and methods for percutaneous access and closure of puncture sites in a body lumen, particularly blood vessels of the human body. It will be appreciated however that application of the present invention is not limited to the blood vasculature, and as such may be applied to any of the vessels, even severely tortuous vessels, ducts, and cavities found in the body as well as tissue tracts. Such closure devices, systems, and methods utilize the body's own natural healing mechanism to achieve complete hemostasis without leaving any foreign objects behind.
- In an embodiment, the device for enhancing the hemostasis of a puncture site in a body lumen or tract comprises a catheter having one tubular member having a proximal end and a distal end with one inner lumen extending along at least a longitudinal portion of the catheter tubular member. The one tubular member includes external and internal tubular bodies each having proximal and distal ends. At least one of the external and the internal tubular bodies is longitudinally movable with respect to the other. An expansible member with proximal and distal ends is disposed on the distal end of the one tubular member. The distal end of the expansible member is attached to the distal end of internal tubular body, while the proximal end of the expansible member is attached to the distal end of external tubular body.
- In an embodiment, the expansible member is expanded by the longitudinal movement of the internal and external tubular bodies with respect to one another. In an embodiment, the expansion is achieved by maintaining the internal tubular body in position while moving the external tubular body distally with respect to the internal tubular body. The degree of expansion of the expansible member in an embodiment is based on the longitudinal displacement between the external and the internal tubular bodies.
- In an embodiment, the expansible member comprises a mesh layer, spring, coil, slotted tube, coiled string, or braided filament such as one with small pores.
- In an embodiment, distal and proximal spacers are disposed at the distal ends of the external and internal tubular bodies, connecting the external and the internal tubular bodies with the proximal and the distal ends of the expansible members; respectively. The outer diameter of the expansible member at the distal and proximal ends may be similar or different (e.g., greater or smaller). In an embodiment, the difference between the outer diameter of the expansible member at its proximal and distal ends affects the direction of the movement of the expansible member upon its expansion. In an embodiment, when the outer diameter at the distal end is less than that at the proximal end, it enables the expansible member to fold forward (in the distal direction) upon expansion. The change in the outer diameter at the distal end of the expansible member may be achieved by providing a distal spacer having a smaller thickness than the proximal spacer, or removing the distal spacer in total.
- In an embodiment, the internal tubular body of the one catheter is configured for fluid communication; at its distal end with the body lumen; and at its proximal end with a mechanism for removal of bodily fluids, such as blood, from the body. The fluid body removal mechanism, may be a syringe or syringe/hemostatic valve mechanism as commonly available.
- In an embodiment, the one catheter is advanced to the body through a puncture site at the skin, tissue/fascia, and then the body lumen. The one expansible member is thereafter expanded intraluminally and seated against a vessel wall. In an embodiment the expansible member is expanded by the internal tubular body moving the external tubular body distally relative to the internal tubular body and subsequently placed against the vessel site at the puncture site. The expansible member may be allowed to remain in the body lumen until the puncture site has healed, after which the expansible member is collapsed and removed slowly from the human body. During the operation, the optional syringe may be used to withdraw bodily fluids using the lumen of the internal tubular body of the one catheter.
- In an embodiment, the one expansible member of the one catheter is advanced to the tissue/fascia, and expanded extraluminally within the fascia along a tissue tract of the puncture site. In an embodiment, the expansible member is expanded by maintaining the internal tubular body stationary while moving the external tubular body distally and thereafter removed upon achieving the desired effect.
- In an embodiment, another catheter having another tubular member with proximal and distal ends and another expansible member with proximal and distal ends disposed on the distal end of the another tubular member is provided. The inner diameter of the internal tubular body of the one catheter and the outer diameter of the tubular member of the another catheter are configured such that the another catheter is disposable within the lumen of the internal tubular body of the one catheter.
- The one and the another catheters may be advanced simultaneously or separately within the body. The expansible members may be, independently, disposed within the body lumen and the tissue/fascia. The expansible members may be expanded simultaneously or sequentially in any order as appropriate. Similarly, the expansible members may be unexpanded and retracted from the body lumen and/or the tissue/fascia as necessary.
- In an embodiment, the one and the another catheters are pre-loaded into one another (e.g., the one catheter is disposed over the another catheter) forming a catheter assembly. As described above, the one and the another catheter may be advanced simultaneously or separately to within the body. The expansible members may be, independently, disposed within the body lumen and the tissue/fascia. The expansible members may be expanded simultaneously or sequentially in any order as appropriate. Similarly, the expansible members may be unexpanded and retracted from the body lumen and/or the tissue/fascia as necessary.
- In an embodiment, either or both of the expansible members may be at least partially covered with a flexible membrane.
- In the operation, in most embodiments, at the completion of a procedure, such as a catheterization procedure, an introducer sheath is disposed through an opening in a skin surface, tissue tract in fascia, and a vessel wall, and is seated in a vessel lumen.
- The one and the another catheter may be introduced alone without the use of the other, or they may be used in conjunction with one another. When used in conjunction with one another, each of the catheters may be introduced together with the other, separately, sequentially, or as an integrated system to the patient's body. In most embodiment, either or both the one and the another catheter are introduced directly or indirectly through the introducer sheath. Either or both the expansible members, independently, may be expanded intraluminally or extraluminally within the tissue/fascia. In some embodiments, a syringe may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internal tubular body.
- In an embodiment, the one catheter is introduced through the sheath and the expansible member is advanced into and deployed within the body lumen. The introducer sheath is then slowly withdrawn from the body, leaving the one expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen. The one catheter including the one expansible member is left in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- In an embodiment, the one catheter is introduced through the sheath and the expansible member is a advanced into the body lumen. The introducer sheath is then slowly withdrawn from the body, leaving the one catheter and the one expansible member in place. The another catheter is then inserted through the proximal end of the one catheter. The another expansible member is advanced within the body lumen to a position distal of the one expansible member. The expansible members are deployed, simultaneously, or separately (in any order desired). The another expansible member is then contracted and the another catheter is pulled proximally and removed from the body through the lumen of the one catheter, leaving the one catheter and the expansible member seating against the vessel wall at the puncture site within the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body. Alternatively, the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- In another embodiment, the another catheter of an assembly comprising both the one and the another catheters, is preloaded within the lumen of the internal tubular body of the one catheter. The distal end of the assembly is then inserted through the sheath and the assembly (including both the one and another catheters) is advanced through an opening in skin, and through tissue tract. The another catheter is advanced until the another expansible member is disposed within the body lumen while the one catheter's expansible member is placed at a predetermined distance from the vessel wall within the tissue/fascia. The introducer sheath is then slowly pulled proximally and retracted from the body lumen, with the one and another expansible members located in the tissue/fascia and the body lumen, respectively. The one and the another expansible members are then expanded in their respective locations, with the one expansible member in the tissue/fascia and the another expansible member seating against the vessel wall at the puncture site within the body lumen. The another expansible member is then contracted and the another catheter is then pulled proximally and removed from the body through the lumen of the one catheter, leaving the one catheter and the one expansible member in the tissue fascia as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body. Alternatively, the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body.
- In another embodiment, the another catheter is preloaded within the lumen of internal tubular body of the one catheter forming the assembly of the two catheters. The distal end of the assembly is then inserted through a hub of the sheath, thereby advancing the assembly through an opening in skin, and through the tissue tract, and within the body lumen. With the one and the another expansible members positioned within the body lumen and expanded, the one expansible member rests against the vessel wall at the puncture site, while the another expansible member is placed against the distal end of the one expansible member. The introducer sheath is then slowly pulled proximally and retracted from the body lumen, leaving the first and second catheters in place within the body lumen. The one expansible member is then contracted and the one catheter is then pulled proximally and removed from the body over the another catheter, leaving the another catheter and the another expansible member in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body. Alternatively, the another expansible member may be contracted and removed from the body lumen first, leaving the one expansible member in place as long as necessary before withdrawing it from the patient's body.
- In another embodiment, the another catheter of the device is inserted through the existing sheath, advancing the another expansible member within the body lumen. The another expansible member is then expanded by holding the distal handle part of another catheter handle assembly stationary and moving the proximal handle part proximally. The introducer sheath is then slowly pulled proximally and retracted from the body lumen, leaving the another catheter in place with the another expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen. The proximal end of the another catheter is pushed through the distal end of the one catheter and fed through the lumen of its internal tubular body until it exists the proximal end of the one catheter. The one catheter is then guided over the tubular member of the another catheter through an opening in skin, through tissue tract, until its distal end is placed at a predetermined distance from the vessel wall and against subcutaneous tissue. The one expansible member is then expanded over the puncture site of the vessel wall by pulling the handle of the external tubular body proximally while maintaining the internal tubular body of the one catheter substantially stationary. The another expansible member is then contracted and the another catheter is then pulled proximally and removed from the body through the lumen of the one catheter, leaving one catheter and the one expansible member in the tissue fascia as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body.
- As can be appreciated, the catheters of assembly may be advanced, expanded, and retracted from the patient's body in any order as may be necessary. Additionally, each of the one expansible member and the another expansible members, when used in combination with one another, may, independently, be expanded within the body lumen or within the tissue/fascia.
- A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.
- The following drawings should be read with reference to the detailed description. Like numbers in different drawings refer to like elements. The drawings, which are not necessarily to scale, illustratively depict embodiments of the present invention and are not intended to limit the scope of the invention.
-
FIG. 1A illustrates a device for enhancing the hemostasis of a puncture site in a body lumen or tract embodying features of the present invention and having an expandable member at a distal end. -
FIG. 1B illustrates an alternative design of the device ofFIG. 1 having a seal at a proximal end of the device. -
FIG. 1C illustrates an alternative design of the device ofFIG. 1 having a detachable syringe at a proximal end of the device for removal of bodily fluids to and from the body lumen. -
FIG. 2 illustrates the device ofFIG. 1 showing the expandable member in an expanded position. -
FIGS. 3-5 , illustrate exemplary embodiments of the expansible member of the device ofFIG. 1 , in expanded configuration. -
FIG. 6 illustrates an assembly for enhancing the hemostasis of a puncture site in a body lumen or tract embodying features of the present invention and including the device ofFIG. 1 and another device disposed within the first device. -
FIG. 7 illustrates the device ofFIG. 6 showing the expandable members in an expanded position. -
FIGS. 8A though 8E illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the device ofFIG. 1 . -
FIGS. 9A though 9G illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown inFIG. 6 . -
FIGS. 10A though 10F illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown inFIG. 6 . -
FIGS. 11A though 11E illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown inFIG. 6 . -
FIGS. 12A through 12H illustrate an exemplary method for hemostasis of a puncture site in a body lumen employing the devices shown inFIG. 6 . -
FIGS. 13A through 13G illustrate the method ofFIGS. 12A through H, with the devices shown in longitudinal cross sectional views. -
FIGS. 1A through 1C andFIG. 2 (in an expanded configuration), illustrate a hemostasis-enhancingdevice 10 embodying features of the present invention and generally comprising onecatheter 13 having onetubular member 16 with proximal anddistal ends tubular body 25, and one elongate externaltubular body 28 slidably disposed over the internaltubular body 25. The inner and externaltubular bodies inner lumens distal end 40 of the externaltubular body 28 is proximally set apart at a longitudinal distance from thedistal end 37 of the internal tubular body. It will be appreciated that the above depictions, as shown, are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of thedevice 10. This applies to all depictions hereinafter. In an embodiment, the inner and/or the outerelongate bodies - One
expansible member 49 with proximal anddistal ends intermediate portion 58 disposed therebetween, is disposed at the distal end of the hemostasis-enhancingdevice 10. Thedistal end 55 of the oneexpansible member 49 is sealingly secured to thedistal end 37 of the internaltubular body 25 at adistal connection point 61, and theproximal end 52 of the one expansible member is sealingly secured to thedistal end 40 of the externaltubular body 28 at aproximal connection point 64; respectively. The proximal anddistal ends expansible member 49 may be separated from the outer and internaltubular bodies distal spacers expansible member 49 with the inner and external tubular bodies may be made with a crimp process, use of shrink tubing such as polyester tubing, adhesives such as glue, heat staking member into member, or a combination thereof. - Optionally, as shown in
FIG. 1B , aseal 73 may be disposed at the proximal end of the internaltubular body 25, or any other suitable position along the length thereof. The seal, by way of example, may be made of any self-sealing material and may include a cross-cut to enable the insertion and/or withdrawal of other elongate members from thelumen 43 of the internaltubular body 25. The one catheter at theproximal end 19, as shown inFIG. 1C , may be equipped with asuitable connector 79 for attaching a syringe (not shown) or the like to deliver fluids to or from the body lumen. By way of example, the syringe may be used to withdraw bodily fluids, such as blood, from the body lumen during the procedure. - Now referring to
FIG. 2 , the one expansible member is shown in expanded configuration with theproximal end 34 of the externaltubular body 28 being distally spaced apart from theproximal end 31 of the internaltubular body 25, causing the radial expansion of the oneexpansible member 49. - In an embodiment, features of which are shown in
FIG. 3 , theouter diameters tubular member 16 at the proximal anddistal ends distal spacer 70 being greater than that of theproximal spacer 67. In this configuration, the expansible member, substantially and uniformly expands upon expansion. Alternatively, as shown inFIG. 4 , the outer diameter of the onetubular member 16 at theproximal end 52 of the oneexpansible member 49 is greater than that at the expansible memberdistal end 55. In another alternate embodiment, as shown inFIG. 5 , the outer diameter of the onetubular member 16 at the proximal end of theexpansible member 49 is relatively much greater than that at the expansible memberdistal end 55. As can be noted, the difference in the outer diameter of the onetubular member 16 at the proximal and distal ends of the expansible member affect the shape of the expansible member upon expansion. By way of example, as can be seen inFIG. 5 , the smaller outer diameter at the distal end of the expansible member, enables the expansible member to fold in the proximal direction upon expansion. The proximal and distal spacers may be used to provide the desired outer diameter relationship at the proximal and distal ends of the expansible member. In some embodiments, the length of the expansible member may configured to provide the desired shape upon expansion (e.g., disc or cylinder). - As further shown in
FIGS. 1A and 1B , ahandle assembly 80 may be removably connectable at theproximal end 19 of the onecatheter 13. In an embodiment, aproximal part 83 of the handle is connectable to theproximal end 31 of the internaltubular body 25 and adistal part 86 is connectable to theproximal end 34 of the externaltubular body 28. Handleparts device 10, allowing the user to more conveniently move either or both the inner and the external tubular bodies with respect to the other for the purpose of deploying and retracting the expansible member. In an embodiment, the external tubular body is longitudinally movable while the internal tubular body is maintained substantially stationary. - The one
catheter 13 and its inner and external tubular bodies may be formed from solid or coiled stainless steel tubing or polymer materials such as nylon, polyurethane, polyimide, PEEK®, PEBAX®, and the like. The catheter may have a length in a range from about 5 centimeters (“cm”) to about 50 cm, preferably in the range from about 10 cm to about 40 cm; and a diameter in the range from about 0.5 millimeters (“mm”) to about 0.6 mm, preferably in the range from about 1 mm to about 4 mm. The inner diameter of the internaltubular body 25, in an embodiment, is sufficiently large to enable housing of another catheter within, as described further below with respect toFIG. 6 . - The maximum outer diameter of the external tubular body of the one catheter, in an embodiment, when the device is used through in dwelling sheath is chosen to be less than the inside diameter of an introducer sheath. For example, when a 5 Fr (French) sheath is used, the maximum diameter of the external tubular body of the one catheter would be less than 1.75 mm. The smaller this difference, the greater the interference between the external tubular body of the one catheter and the sheath.
- The one expansible
member 49 in a retracted or unexpanded state has a diameter of less than about 10 mm, preferably less than about 4 mm, as shown inFIG. 1A . When deployed, the oneexpansible member 49 in an expanded state has a diameter in a range from about 2 mm to about 25 mm, preferably from about 4 mm to about 15 mm, as shown inFIG. 2 (or the other expanded embodiments shown). The expanded diameter, as referenced, is measured at the largest nominal external diameter, as for example, at theintermediate portion 58. Exemplary expansible member structures are described in detail in U.S. Pat. No. 5,836,913 and co-pending U.S. patent application Ser. No. 10/718,504, both assigned to the assignee of the present application and incorporated herein by reference in their entirety. - The
expansible member 49 may comprise a variety of structures including a braided filament, mesh layer, spring, coil, slotted tube, or balloon. Optionally, as shown inFIG. 1A , adeformable membrane 90 may be at least partially disposed over the oneexpansible member 49. However, in the case where the expansible member comprises a braided mesh, the braid may be sufficiently tight such that without the use of a membrane in a deployed state, it can adequately occlude the puncture site in the vessel. The expansible member may also be coated with a highly hydrophobic coating such as TEFLON® or HYDRO-SIL®. The combination of small pores in the braided mesh and high surface tension of the expansible member achieved by the use of such coatings may provide an adequate barrier to blood flow through the puncture site. The expansible member occludes the vascular surface at the puncture site without substantially disturbing the blood flow to the lower extremities. - The
optional membrane 90 may be formed from a variety of medical grade materials, such as thermoplastic elastomers (e.g., CHRONOPRENE® or POLYBLEND®) having durometers in a range from 15A to about 40A. Adhesives such as LOCTITE® 4014 may be used to attach the optional membrane to the onecatheter tubular body 16 at the proximal and distal connection points, 93 and 96. Alternatively, the membrane may take a form of a sock having its distal end sealed through a heat stake process or the like. In this case, the membrane may not have to be attached distally. The optional membrane preferably has a diameter that is sufficient to cover the expansible member. In some embodiments, the membrane may be designed and attached to facilitate one expansible member expansion as well as to reduce the amount of required elongation and the stretch of the membrane when the expansible member is deployed. This may be achieved by molding the membrane so that its midpoint diameter, where deployed expansible member has its greatest diameter, is larger than its proximal and distal end diameters (e.g., a spherical shape). The membrane may also be formed like a tube with a larger diameter than needed (diameter of retracted expansible member), and then stretched over the expansible member and attached. The stretch should be enough to reduce the diameter of the membrane to that of the expansible member. In such a case, when the one expansible member is deployed, there is less elongation and stress experienced by the membrane. The membrane may additionally form a membrane tip (not shown) at the distal end of the catheter so as to provide a soft and blunt point for percutaneous access. In other embodiments, a flexible tip deflector may be coupleable to the catheter body distal the expansible member so as to prevent any damage to the surrounding vessel wall. The use of the membrane is preferred when the expansible member is used for intraluminal expansion within a target site in the body of the patient. - Referring now to
FIGS. 6-7 , a hemostasis-enhancingassembly 500, wherein like references represent like elements, includes the hemostasis-enhancingdevice 10, and anotherdevice 20 generally comprising anotherflexible catheter 213 that is slidably disposable within the internaltubular body 25 of the onecatheter 13. The anothercatheter 213 may be removably disposable within the inner lumen of the one catheter or the two catheters may be integrally formed with one another, forming asingle catheter assembly 500. - The another
flexible catheter 213, as shown, generally includes another elongatetubular member 216 with proximal and a distal ends 219 and 222. The anothercatheter 213 may be of any suitable construction as for example, detailed in co-pending U.S. patent application Ser. No. 10/974,008 (Attorney Docket No. 021872-002010US), filed on Oct. 25, 2004; Ser. No. 10/857,177, (Attorney Docket No. 021872-002000US), filed May 27, 2004; Ser. No. 10/821,633, (Attorney Docket No. 021872-001900US), filed on Apr. 9, 2004; the full disclosures of which are incorporated herein by reference in their entirety. - The another catheter's elongate
tubular member 216 may be formed from coiled stainless steel tubing or polymer materials such as nylon, polyurethane, polyimide, PEEK®, PEBAX®, and the like. The another elongatetubular member 216 may have a length in a range from about 10 cm to about 50 cm, preferably in the range from about 15 cm to about 30 cm and a diameter in the range from about 0.25 mm to about 5 mm, preferably in the range from about 0.5 mm to about 2 mm. Anotherexpansible member 249 is disposed at thedistal end 222 of the another elongate member. Exemplary expansible member structures are described in detail in co-pending U.S. patent application Ser. No. 10/974,008 filed on Oct. 25, 2004 (Attorney Docket No. 021872-002010US), assigned to the assignee of the present application and incorporated herein by reference in its entirety. - The another
expansible member 249 in a retracted or unexpanded state has an outer diameter of less than about 5 mm, preferably less than about 3 mm, as shown inFIG. 6 . When deployed, the anotherexpansible member 249 in an expanded state has an outer diameter in a range from about 2 mm to about 25 mm, preferably from about 3 mm to about 10 mm, as shown inFIG. 7 . The expanded diameter, as referenced, is measured at the largest nominal external diameter, as for example, at anintermediate portion 258. - The another expansible member, may similar to the one expansible member, be, at least partially, covered by another
optional membrane 290, as described in reference to the one expansible member, and with independently selected features or characteristics as described above. - Another
handle assembly 280 may be removably connectable at theproximal end 219 of the anotherelongate member 216. In an embodiment, handleparts device 20, allowing the user to more conveniently move the anotherelongate member 216 in and out of the onecatheter 10, as well as deploying and retracting the anotherexpansible member 249. The longitudinal movement of theproximal handle part 283 of the anotherelongate member 216 will enable the deployment or retraction of the anotherexpansible member 249. The anotherexpansible member 249 may comprise a push or a pull type deployment means as is described in detail in co-pending U.S. patent application Ser. No. 10/821,633 (Attorney Docket No. 021872-001900US), filed on Apr. 9, 2004, assigned to the assignee of the present application and incorporated herein by reference in its entirety. Exemplary expansible member structures are described in detail in co-pending U.S. patent application Ser. No. 10/718,504 (Attorney Docket No. 021872-001010US), filed on Nov. 19, 2003, assigned to the assignee of the present application and incorporated herein by reference in its entirety. Still further embodiments of other expansible braided mesh members are disclosed in U.S. Pat. No. 5,836,913, also incorporated herein by reference in its entirety. - The operation and use of
device 10 alone or in combination withdevice 20, as separate devices, or asassembly 500, are described below. As can be appreciated, many of the details previously described do not necessarily appear in the method figures for purposes of clarity. - Referring to
FIGS. 8A through 8E , features of an exemplary method for hemostasis of a puncture site in a body lumen employing the device ofFIGS. 1A through 1C are illustrated.FIG. 8A depicts anexisting introducer sheath 400 disposed through an opening in askin surface 403, tissue tract infascia 406, andvessel wall 409 and seated in avessel lumen 412, at the completion of a catheterization procedure. - The device 10 (e.g., of
FIG. 1A ), is then inserted through ahub 415 of thesheath 400 to a marking, such as when the distal end of thedistal handle part 86 of the onecatheter 10 rests against the hub of the sheath, as shown inFIG. 8B , thereby advancing the oneexpansible member 49 within thebody lumen 412. As shown inFIG. 8C , the oneexpansible member 49 is then deployed within the body lumen by moving theproximal handle part 83 of the onecatheter handle assembly 80 relative to thedistal handle part 86, as described relative toFIGS. 1 and 2 . Theintroducer sheath 400 is then slowly pulled proximally and retracted (not shown) from the body lumen, leaving the one catheter in place with the one expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen. The one catheter including the oneexpansible member 49 is left in body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis (FIG. 8D ), after which it is removed from the patient's body (FIG. 8E ). During the procedure, the syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internaltubular body 25. - Referring now to
FIGS. 9A through 9G , features of an exemplary method for hemostasis of a puncture site in a body lumen employing thedevices FIGS. 6-7 is illustrated.FIG. 9A depicts anexisting introducer sheath 400 disposed through an opening in askin surface 403, tissue tract infascia 406, andvessel wall 409 and seated in avessel lumen 412, at the completion of a catheterization procedure. - The device 10 (e.g., of
FIG. 1A ), is then inserted through ahub 415 of thesheath 400 to a marking, such as when the distal end of thedistal handle part 86 of the onecatheter 10 rests against the hub of the sheath, as shown inFIG. 9B , thereby advancing the oneexpansible member 49 within the body lumen. The introducer sheath is then slowly pulled proximally and retracted (not shown) from the body lumen, leaving the one catheter in place (FIG. 9C ). - The another
catheter 213 of thedevice 20 is then inserted through theproximal end 19 of the one catheter 13 (e.g., seal 73 of one catheter ofFIG. 1B ), thereby advancing the anotherexpansible member 249 distal to the one expansible member and within the body lumen (FIG. 9D ). As shown inFIG. 9E , theexpansible members catheter 13 and the anothercatheter 213 are pulled proximally to place theexpansible member 49 against the vessel wall and the anotherexpansible member 249 against the distal opening of the onecatheter 13, so that in combination, the two catheters can help achieve sufficient blockage of the puncture site. - The another
expansible member 249 is then contracted and anothercatheter 213 is then pulled proximally and removed from the body (not shown) through the lumen of the onecatheter 13, leaving the one catheter and the one expansible member seating against (FIG. 9F ) the vessel wall at the puncture site within the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body (FIG. 9G ). During the procedure, a syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through the lumen of the internaltubular body 25. Alternatively, the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body. - Referring to
FIGS. 10A through 10F , features of an exemplary method for hemostasis of a puncture site in a body lumen employing theassembly 500 comprisingdevices FIGS. 6-7 is illustrated.FIG. 10A depicts anexisting introducer sheath 400 disposed through an opening in askin surface 403, tissue tract infascia 406, andvessel wall 409 and seated in avessel lumen 412, at the completion of a catheterization procedure. - The another
catheter 213 of theassembly 500 is preloaded within thelumen 43 of the internaltubular body 25 of the onecatheter 13. The distal end of theassembly 500 is then inserted through ahub 415 of thesheath 400, thereby advancing theassembly 500 including both the one and another catheters through an opening inskin 403, throughtissue tract 406. The anothercatheter 216 is advanced until the another expansible member is disposed within thebody lumen 412 while the one catheter'sexpansible member 49 is placed at a predetermined distance from thevessel wall 409 within the tissue/fascia 406 (FIG. 10B ). Theintroducer sheath 400 is then slowly pulled proximally and retracted (not shown) from the body lumen, with the one and another expansible members located in the tissue/fascia and the body lumen, respectively (FIG. 10C ). - As shown in
FIG. 10D , the one and the another expansible members are then expanded in their respective locations, with the one expansible member in the tissue/fascia and the another expansible member seating against the vessel wall at the puncture site within the body lumen. - The another
expansible member 249 is then contracted and the anothercatheter 213 is then pulled proximally and removed (not shown) from the body through the lumen of the onecatheter 13, leaving one catheter and the oneexpansible member 49 in the tissue fascia (FIG. 10E ) as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body (FIG. 10F ). During the procedure, a syringe (not shown), may be used to draw bodily fluids, such as blood, from the body lumen through thelumen 43 of the internaltubular body 25. Alternatively, the one expansible member may be contracted and removed from the body lumen first, leaving the another expansible member in place as long as necessary before withdrawing it from the patient's body. - Referring now to
FIGS. 11A through 11E , features of a method for hemostasis of a puncture site in a body lumen employing theassembly 500 comprisingdevices 10 and 11 ofFIGS. 6-7 is illustrated.FIG. 11A depicts anexisting introducer sheath 400 disposed through an opening in askin surface 403, tissue tract infascia 406, andvessel wall 409 and seated in avessel lumen 412, at the completion of a catheterization procedure. - The another
catheter 213 of theassembly 500 is preloaded within thelumen 43 of internaltubular body 25 of the onecatheter 13. The distal end of theassembly 500 is then inserted through a hub of thesheath 400, thereby advancing theassembly 500 including both the one and another catheters through an opening inskin 403, throughtissue tract 409. - With the one and the another expansible members positioned within the body lumen and expanded, the one expansible member rests against the vessel wall at the puncture site, while the another expansible member is placed against the distal end of the one expansible member.
- The
introducer sheath 400 is then slowly pulled proximally and retracted (not shown) from thebody lumen 412, leaving the first and second catheters in place within the body lumen (FIG. 11C ). - The one expansible
member 49 is then contracted and the onecatheter 13 is then pulled proximally and removed (FIG. 11D ) from the body over the anothercatheter 213, leaving the another catheter and the anotherexpansible member 249 in the body lumen as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body (FIG. 11E ). During the procedure, a syringe (now shown), may be used to draw bodily fluids, such as blood, from the body lumen through thelumen 43 of the internaltubular body 25. Alternatively, the another expansible member may be contracted and removed from the body lumen first, leaving the one expansible member in place as long as necessary before withdrawing it from the patient's body. - Now, referring to
FIGS. 12A-12H and 13A-13G, features of an exemplary method for hemostasis of a puncture site in a body lumen employing thedevice FIGS. 6-7 is illustrated.FIGS. 12A and 13A depict an existingintroducer sheath 400 disposed through an opening in askin surface 403, tissue tract infascia 406, andvessel wall 409 and seated in avessel lumen 412, at the completion of a catheterization procedure. - The another catheter 123 of the of
device 20 is then inserted through ahub 415 of thesheath 400 to a marking, such as when the distal end of the distal handle part of the another catheter rests against the hub of the sheath, as shown inFIGS. 12B and 13B , thereby advancing the anotherexpansible member 249 within thebody lumen 412. As shown inFIGS. 12C and 13C , the anotherexpansible member 249 is then expanded by holding thedistal handle part 286 of another catheter handle assembly stationary and moving theproximal handle part 283 proximally. Theintroducer sheath 400 is then slowly pulled proximally and retracted from the body lumen (not shown), leaving the another catheter in place with the another expansible member in expanded position seating against the vessel wall at the puncture site within the body lumen (FIGS. 12D and 13D ). - Now referring to FIGS. 12E and 13E1-E2, the proximal end of the another
catheter 213 is pushed through the distal end of the onecatheter 13 and fed through the lumen of its internal tubular body until it exits the proximal end of the one catheter. The one catheter is then guided over the tubular member of the another catheter through an opening in skin, through tissue tract, until its distal end is placed at a predetermined distance from the vessel wall and against subcutaneous tissue. The one expansible member is then expanded over the puncture site of the vessel wall by pulling the handle of the external tubular body proximally while maintaining the internal tubular body of the one catheter substantially stationary (FIGS. 12F and 13F ). - The another
expansible member 249 is then contracted and the another catheter 123 is then pulled proximally and removed (not shown) from the body through the lumen of the one catheter, leaving the one catheter and the one expansible member in the tissue fascia (FIGS. 12G and 13G ) as long as necessary to allow the body's own natural wound healing mechanism to achieve hemostasis, after which it is removed from the patient's body (FIG. 12H ). During the procedure, the syringe, as for example shown inFIG. 1C , may be used to draw bodily fluids, such as blood, from the body through the lumen of the internal tubular body. - As can be appreciated, the catheters of
assembly 500 may be advanced, expanded, and retracted from the patient's body in any order as may be necessary. Additionally, each of the one expansible member and the another expansible members, when used in combination with one another, may, independently, be expanded within the body lumen or within the tissue/fascia. - Although certain exemplary embodiments and methods have been described in some detail, for clarity of understanding and by way of example, it will be apparent from the foregoing disclosure to those skilled in the art that variations, modifications, changes, and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Claims (53)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/614,276 US20080154303A1 (en) | 2006-12-21 | 2006-12-21 | Hemostasis-enhancing device and method for its use |
PCT/US2007/087885 WO2008079810A2 (en) | 2006-12-21 | 2007-12-18 | Hemostasis-enhancing device and method for its use |
US12/895,205 US8444671B2 (en) | 2006-12-21 | 2010-09-30 | Hemostasis-enhancing device and method for its use |
US13/868,775 US9427221B2 (en) | 2004-04-09 | 2013-04-23 | Hemostasis-enhancing device and method for its use |
US15/217,395 US10130347B2 (en) | 2006-12-21 | 2016-07-22 | Hemostasis-enhancing device and method for its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/614,276 US20080154303A1 (en) | 2006-12-21 | 2006-12-21 | Hemostasis-enhancing device and method for its use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/895,205 Division US8444671B2 (en) | 2004-04-09 | 2010-09-30 | Hemostasis-enhancing device and method for its use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080154303A1 true US20080154303A1 (en) | 2008-06-26 |
Family
ID=39544004
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/614,276 Abandoned US20080154303A1 (en) | 2004-04-09 | 2006-12-21 | Hemostasis-enhancing device and method for its use |
US12/895,205 Active 2027-03-15 US8444671B2 (en) | 2004-04-09 | 2010-09-30 | Hemostasis-enhancing device and method for its use |
US13/868,775 Active US9427221B2 (en) | 2004-04-09 | 2013-04-23 | Hemostasis-enhancing device and method for its use |
US15/217,395 Active 2027-06-18 US10130347B2 (en) | 2006-12-21 | 2016-07-22 | Hemostasis-enhancing device and method for its use |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/895,205 Active 2027-03-15 US8444671B2 (en) | 2004-04-09 | 2010-09-30 | Hemostasis-enhancing device and method for its use |
US13/868,775 Active US9427221B2 (en) | 2004-04-09 | 2013-04-23 | Hemostasis-enhancing device and method for its use |
US15/217,395 Active 2027-06-18 US10130347B2 (en) | 2006-12-21 | 2016-07-22 | Hemostasis-enhancing device and method for its use |
Country Status (2)
Country | Link |
---|---|
US (4) | US20080154303A1 (en) |
WO (1) | WO2008079810A2 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090125056A1 (en) * | 2007-08-15 | 2009-05-14 | Cardiodex Ltd. | Systems and methods for puncture closure |
WO2010002918A1 (en) | 2008-06-30 | 2010-01-07 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US20100152748A1 (en) * | 2008-12-12 | 2010-06-17 | E-Pacing, Inc. | Devices, Systems, and Methods Providing Body Lumen Access |
US20110106012A1 (en) * | 2009-10-29 | 2011-05-05 | Velarde Franz E | Sheath Introducer with Self-Anchoring Mechanism |
US8372072B2 (en) | 2003-02-04 | 2013-02-12 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US8435236B2 (en) | 2004-11-22 | 2013-05-07 | Cardiodex, Ltd. | Techniques for heat-treating varicose veins |
US8444671B2 (en) | 2006-12-21 | 2013-05-21 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US8506592B2 (en) | 2008-08-26 | 2013-08-13 | St. Jude Medical, Inc. | Method and system for sealing percutaneous punctures |
US8845682B2 (en) | 2009-10-13 | 2014-09-30 | E-Pacing, Inc. | Vasculature closure devices and methods |
US8911472B2 (en) | 2005-12-13 | 2014-12-16 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US10085731B2 (en) | 2013-07-15 | 2018-10-02 | E-Pacing, Inc. | Vasculature closure devices and methods |
US20190015086A1 (en) * | 2017-07-16 | 2019-01-17 | Steven Jay Blumenthal | Balloon Closure Device |
US20200129164A1 (en) * | 2018-10-24 | 2020-04-30 | M-V Arterica AB | Self-expanding hemostatic devices and methods for fascia and vessel passages |
US10960100B2 (en) | 2012-06-22 | 2021-03-30 | Z-Medica, Llc | Hemostatic devices |
US10960101B2 (en) | 2006-05-26 | 2021-03-30 | Z-Medica, Llc | Clay-based hemostatic agents |
US11007218B2 (en) | 2010-09-22 | 2021-05-18 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US11167058B2 (en) | 2005-02-15 | 2021-11-09 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow |
US11938288B2 (en) | 2019-11-19 | 2024-03-26 | Arterica Inc. | Vascular closure devices and methods |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10085730B2 (en) | 2013-07-12 | 2018-10-02 | Phillips Medical, LLC | Hemostatic device and its methods of use |
US9839416B2 (en) | 2013-07-12 | 2017-12-12 | Phillips Medical, LLC | Hemostatic device and its methods of use |
EP3294146A1 (en) * | 2015-05-11 | 2018-03-21 | Phillips Medical, LLC | Hemostatic device and its methods of use |
Citations (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US557652A (en) * | 1896-04-07 | William daniels and ernest clarence daniels | ||
US656207A (en) * | 1899-12-06 | 1900-08-21 | Henry A Osborne | Trolley-wheel. |
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4852568A (en) * | 1987-02-17 | 1989-08-01 | Kensey Nash Corporation | Method and apparatus for sealing an opening in tissue of a living being |
US4890612A (en) * | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US5061274A (en) * | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
US5108421A (en) * | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5122122A (en) * | 1989-11-22 | 1992-06-16 | Dexide, Incorporated | Locking trocar sleeve |
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5197971A (en) * | 1990-03-02 | 1993-03-30 | Bonutti Peter M | Arthroscopic retractor and method of using the same |
US5258000A (en) * | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5290552A (en) * | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
US5292332A (en) * | 1992-07-27 | 1994-03-08 | Lee Benjamin I | Methods and device for percutanceous sealing of arterial puncture sites |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5395383A (en) * | 1991-10-18 | 1995-03-07 | Ethicon, Inc. | Adhesion barrier applicator |
US5413571A (en) * | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5419765A (en) * | 1990-12-27 | 1995-05-30 | Novoste Corporation | Wound treating device and method for treating wounds |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US5507744A (en) * | 1992-04-23 | 1996-04-16 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5626601A (en) * | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5728134A (en) * | 1996-09-17 | 1998-03-17 | Barak; Shlomo | Method and apparatus for hemostasis |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5810810A (en) * | 1992-04-23 | 1998-09-22 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5836913A (en) * | 1997-05-02 | 1998-11-17 | Innerdyne, Inc. | Device and method for accessing a body cavity |
US5851210A (en) * | 1997-03-21 | 1998-12-22 | Torossian; Richard | Stent delivery system and method |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5868778A (en) * | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5906631A (en) * | 1997-12-05 | 1999-05-25 | Surface Genesis, Inc. | Method and device for sealing vascular puncture wounds |
US5951583A (en) * | 1993-05-25 | 1999-09-14 | Vascular Solutions, Inc. | Thrombin and collagen procoagulant and process for making the same |
US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6017359A (en) * | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US6048358A (en) * | 1998-07-13 | 2000-04-11 | Barak; Shlomo | Method and apparatus for hemostasis following arterial catheterization |
US6048368A (en) * | 1995-11-27 | 2000-04-11 | The Proctor & Gamble Company | Cleaning method for textile fabrics |
US6056769A (en) * | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US6056770A (en) * | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and method |
US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6146396A (en) * | 1999-03-05 | 2000-11-14 | Board Of Regents, The University Of Texas System | Declotting method and apparatus |
US6248124B1 (en) * | 1999-02-22 | 2001-06-19 | Tyco Healthcare Group | Arterial hole closure apparatus |
US6287323B1 (en) * | 1993-09-28 | 2001-09-11 | Hemodynamics, Inc. | Method of catheterization and inhibition of arterial bleeding |
US6296657B1 (en) * | 1998-10-07 | 2001-10-02 | Gregory G. Brucker | Vascular sealing device and method |
US20010047187A1 (en) * | 1998-11-06 | 2001-11-29 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US20020026215A1 (en) * | 1998-08-04 | 2002-02-28 | Redmond Russell J. | Percutaneous tissue track closure assembly and method |
US6371975B2 (en) * | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
US20020072767A1 (en) * | 2000-08-02 | 2002-06-13 | Zhu Yong Hua | Method and apparatus for closing vascular puncture using hemostatic material |
US6409739B1 (en) * | 1997-05-19 | 2002-06-25 | Cardio Medical Solutions, Inc. | Device and method for assisting end-to side anastomosis |
US20020133123A1 (en) * | 2001-03-14 | 2002-09-19 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
US6464712B1 (en) * | 1997-02-11 | 2002-10-15 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and method |
US20030120291A1 (en) * | 2001-12-26 | 2003-06-26 | Chin Albert K. | Temporary seal and method for facilitating anastomosis |
US20030191493A1 (en) * | 2002-04-05 | 2003-10-09 | Epstein Gordon H. | Device for clot retrieval and distal protection |
US20040176798A1 (en) * | 1997-02-11 | 2004-09-09 | Cardiva Medical, Inc. | Expansile device for use in blood vessels and tracts in the body and method |
US6913614B2 (en) * | 2003-05-08 | 2005-07-05 | Cardia, Inc. | Delivery system with safety tether |
US20050228443A1 (en) * | 2004-04-09 | 2005-10-13 | Cardiva Medical, Inc. | Device and method for sealing blood vessels |
US20050267522A1 (en) * | 2004-05-27 | 2005-12-01 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US20050277980A1 (en) * | 2004-05-27 | 2005-12-15 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US7025776B1 (en) * | 2001-04-24 | 2006-04-11 | Advanced Catheter Engineering, Inc. | Arteriotomy closure devices and techniques |
US20060195069A1 (en) * | 2004-09-24 | 2006-08-31 | Opie John C | Percutaneous diagnostic and therapeutic hematoma drain |
US7115127B2 (en) * | 2003-02-04 | 2006-10-03 | Cardiodex, Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7223266B2 (en) * | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391183A (en) * | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
NL9101051A (en) | 1991-06-18 | 1993-01-18 | Ashridge Ag | CLOSING DEVICE FOR A VESSEL OR THE LIKE. |
US5411520A (en) * | 1991-11-08 | 1995-05-02 | Kensey Nash Corporation | Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use |
US5342393A (en) * | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
AU7669994A (en) | 1993-08-12 | 1995-03-14 | Vascular Technologies, Inc. | Catheter introducer with suture capability |
US5649959A (en) | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
US6994689B1 (en) | 1995-06-05 | 2006-02-07 | Medtronic Vascular, Inc. | Occlusion of a vessel |
US5951589A (en) | 1997-02-11 | 1999-09-14 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
AU6457298A (en) | 1997-03-12 | 1998-09-29 | Advanced Closure Systems, Inc. | Vascular sealing device |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6080183A (en) * | 1998-11-24 | 2000-06-27 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
JP4953540B2 (en) * | 2000-02-24 | 2012-06-13 | ローマ リンダ ユニヴァーシティ メディカル センター | Patch and adhesive delivery system for closing tissue openings during surgery |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6846321B2 (en) * | 2000-06-21 | 2005-01-25 | Cardiodex, Ltd. | Mechanical method and apparatus for enhancing hemostatis following arterial catheterization |
US7331976B2 (en) | 2003-04-29 | 2008-02-19 | Rex Medical, L.P. | Distal protection device |
US20080154303A1 (en) | 2006-12-21 | 2008-06-26 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US7220246B2 (en) | 2004-07-14 | 2007-05-22 | Medical Components, Inc. | Catheter hub clip |
US20080086109A1 (en) * | 2004-11-29 | 2008-04-10 | Paul Shabty | Arterial closure device |
US7691127B2 (en) * | 2005-12-13 | 2010-04-06 | Cardiva Medical, Inc. | Drug eluting vascular closure devices and methods |
US7789893B2 (en) * | 2006-09-12 | 2010-09-07 | Boston Scientific Scimed, Inc. | Method and apparatus for promoting hemostasis of a blood vessel puncture |
-
2006
- 2006-12-21 US US11/614,276 patent/US20080154303A1/en not_active Abandoned
-
2007
- 2007-12-18 WO PCT/US2007/087885 patent/WO2008079810A2/en active Application Filing
-
2010
- 2010-09-30 US US12/895,205 patent/US8444671B2/en active Active
-
2013
- 2013-04-23 US US13/868,775 patent/US9427221B2/en active Active
-
2016
- 2016-07-22 US US15/217,395 patent/US10130347B2/en active Active
Patent Citations (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US557652A (en) * | 1896-04-07 | William daniels and ernest clarence daniels | ||
US656207A (en) * | 1899-12-06 | 1900-08-21 | Henry A Osborne | Trolley-wheel. |
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4852568A (en) * | 1987-02-17 | 1989-08-01 | Kensey Nash Corporation | Method and apparatus for sealing an opening in tissue of a living being |
US4890612A (en) * | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US5290552A (en) * | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
US5122122A (en) * | 1989-11-22 | 1992-06-16 | Dexide, Incorporated | Locking trocar sleeve |
US5061274A (en) * | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
US5197971A (en) * | 1990-03-02 | 1993-03-30 | Bonutti Peter M | Arthroscopic retractor and method of using the same |
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5108421A (en) * | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5419765A (en) * | 1990-12-27 | 1995-05-30 | Novoste Corporation | Wound treating device and method for treating wounds |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5395383A (en) * | 1991-10-18 | 1995-03-07 | Ethicon, Inc. | Adhesion barrier applicator |
US5258000A (en) * | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5810810A (en) * | 1992-04-23 | 1998-09-22 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5507744A (en) * | 1992-04-23 | 1996-04-16 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
US5630833A (en) * | 1992-07-16 | 1997-05-20 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5413571A (en) * | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5292332A (en) * | 1992-07-27 | 1994-03-08 | Lee Benjamin I | Methods and device for percutanceous sealing of arterial puncture sites |
US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5951583A (en) * | 1993-05-25 | 1999-09-14 | Vascular Solutions, Inc. | Thrombin and collagen procoagulant and process for making the same |
US6017359A (en) * | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US6287323B1 (en) * | 1993-09-28 | 2001-09-11 | Hemodynamics, Inc. | Method of catheterization and inhibition of arterial bleeding |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US6371974B1 (en) * | 1995-09-15 | 2002-04-16 | Sub Q, Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US5868778A (en) * | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US5626601A (en) * | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
US6048368A (en) * | 1995-11-27 | 2000-04-11 | The Proctor & Gamble Company | Cleaning method for textile fabrics |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5728134A (en) * | 1996-09-17 | 1998-03-17 | Barak; Shlomo | Method and apparatus for hemostasis |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5922009A (en) * | 1997-02-11 | 1999-07-13 | Biointerventional Coporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US6464712B1 (en) * | 1997-02-11 | 2002-10-15 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and method |
US20040176798A1 (en) * | 1997-02-11 | 2004-09-09 | Cardiva Medical, Inc. | Expansile device for use in blood vessels and tracts in the body and method |
US6056769A (en) * | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US6056770A (en) * | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and method |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5851210A (en) * | 1997-03-21 | 1998-12-22 | Torossian; Richard | Stent delivery system and method |
US5836913A (en) * | 1997-05-02 | 1998-11-17 | Innerdyne, Inc. | Device and method for accessing a body cavity |
US6409739B1 (en) * | 1997-05-19 | 2002-06-25 | Cardio Medical Solutions, Inc. | Device and method for assisting end-to side anastomosis |
US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US5906631A (en) * | 1997-12-05 | 1999-05-25 | Surface Genesis, Inc. | Method and device for sealing vascular puncture wounds |
US6048358A (en) * | 1998-07-13 | 2000-04-11 | Barak; Shlomo | Method and apparatus for hemostasis following arterial catheterization |
US20020026215A1 (en) * | 1998-08-04 | 2002-02-28 | Redmond Russell J. | Percutaneous tissue track closure assembly and method |
US6296657B1 (en) * | 1998-10-07 | 2001-10-02 | Gregory G. Brucker | Vascular sealing device and method |
US6949114B2 (en) * | 1998-11-06 | 2005-09-27 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US20010047187A1 (en) * | 1998-11-06 | 2001-11-29 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US6371975B2 (en) * | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
US6248124B1 (en) * | 1999-02-22 | 2001-06-19 | Tyco Healthcare Group | Arterial hole closure apparatus |
US6146396A (en) * | 1999-03-05 | 2000-11-14 | Board Of Regents, The University Of Texas System | Declotting method and apparatus |
US20020072767A1 (en) * | 2000-08-02 | 2002-06-13 | Zhu Yong Hua | Method and apparatus for closing vascular puncture using hemostatic material |
US20030055454A1 (en) * | 2001-03-14 | 2003-03-20 | Cardiodex Ltd. | Balloon method and apparatus for vascular closure following arterial catheterization |
US20020133123A1 (en) * | 2001-03-14 | 2002-09-19 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
US7025776B1 (en) * | 2001-04-24 | 2006-04-11 | Advanced Catheter Engineering, Inc. | Arteriotomy closure devices and techniques |
US20030120291A1 (en) * | 2001-12-26 | 2003-06-26 | Chin Albert K. | Temporary seal and method for facilitating anastomosis |
US20030191493A1 (en) * | 2002-04-05 | 2003-10-09 | Epstein Gordon H. | Device for clot retrieval and distal protection |
US7115127B2 (en) * | 2003-02-04 | 2006-10-03 | Cardiodex, Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7223266B2 (en) * | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US6913614B2 (en) * | 2003-05-08 | 2005-07-05 | Cardia, Inc. | Delivery system with safety tether |
US20050228443A1 (en) * | 2004-04-09 | 2005-10-13 | Cardiva Medical, Inc. | Device and method for sealing blood vessels |
US20050267522A1 (en) * | 2004-05-27 | 2005-12-01 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US20050277980A1 (en) * | 2004-05-27 | 2005-12-15 | Cardiva Medical, Inc. | Self-tensioning vascular occlusion device and method for its use |
US20060195069A1 (en) * | 2004-09-24 | 2006-08-31 | Opie John C | Percutaneous diagnostic and therapeutic hematoma drain |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8372072B2 (en) | 2003-02-04 | 2013-02-12 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US9427221B2 (en) | 2004-04-09 | 2016-08-30 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US8435236B2 (en) | 2004-11-22 | 2013-05-07 | Cardiodex, Ltd. | Techniques for heat-treating varicose veins |
US11167058B2 (en) | 2005-02-15 | 2021-11-09 | Virginia Commonwealth University | Hemostasis of wound having high pressure blood flow |
US9439637B2 (en) | 2005-12-13 | 2016-09-13 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US8911472B2 (en) | 2005-12-13 | 2014-12-16 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US10327747B2 (en) | 2005-12-13 | 2019-06-25 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US11123451B2 (en) | 2006-05-26 | 2021-09-21 | Z-Medica, Llc | Hemostatic devices |
US10960101B2 (en) | 2006-05-26 | 2021-03-30 | Z-Medica, Llc | Clay-based hemostatic agents |
US10130347B2 (en) * | 2006-12-21 | 2018-11-20 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US20160324513A1 (en) * | 2006-12-21 | 2016-11-10 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US8444671B2 (en) | 2006-12-21 | 2013-05-21 | Cardiva Medical, Inc. | Hemostasis-enhancing device and method for its use |
US20090125056A1 (en) * | 2007-08-15 | 2009-05-14 | Cardiodex Ltd. | Systems and methods for puncture closure |
US8366706B2 (en) | 2007-08-15 | 2013-02-05 | Cardiodex, Ltd. | Systems and methods for puncture closure |
US20100168767A1 (en) * | 2008-06-30 | 2010-07-01 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US11717278B2 (en) | 2008-06-30 | 2023-08-08 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
WO2010002918A1 (en) | 2008-06-30 | 2010-01-07 | Cardiva Medical, Inc. | Apparatus and methods for delivering hemostatic materials for blood vessel closure |
US8845683B2 (en) | 2008-08-26 | 2014-09-30 | St. Jude Medical, Inc. | Method and system for sealing percutaneous punctures |
US8506592B2 (en) | 2008-08-26 | 2013-08-13 | St. Jude Medical, Inc. | Method and system for sealing percutaneous punctures |
US20100152748A1 (en) * | 2008-12-12 | 2010-06-17 | E-Pacing, Inc. | Devices, Systems, and Methods Providing Body Lumen Access |
US8845682B2 (en) | 2009-10-13 | 2014-09-30 | E-Pacing, Inc. | Vasculature closure devices and methods |
US20110106012A1 (en) * | 2009-10-29 | 2011-05-05 | Velarde Franz E | Sheath Introducer with Self-Anchoring Mechanism |
US11007218B2 (en) | 2010-09-22 | 2021-05-18 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US10960100B2 (en) | 2012-06-22 | 2021-03-30 | Z-Medica, Llc | Hemostatic devices |
US11559601B2 (en) | 2012-06-22 | 2023-01-24 | Teleflex Life Sciences Limited | Hemostatic devices |
US10085731B2 (en) | 2013-07-15 | 2018-10-02 | E-Pacing, Inc. | Vasculature closure devices and methods |
US10952710B2 (en) * | 2017-07-16 | 2021-03-23 | Steven Jay Blumenthal | Balloon closure device |
US20190015086A1 (en) * | 2017-07-16 | 2019-01-17 | Steven Jay Blumenthal | Balloon Closure Device |
US20200129164A1 (en) * | 2018-10-24 | 2020-04-30 | M-V Arterica AB | Self-expanding hemostatic devices and methods for fascia and vessel passages |
US11938288B2 (en) | 2019-11-19 | 2024-03-26 | Arterica Inc. | Vascular closure devices and methods |
Also Published As
Publication number | Publication date |
---|---|
US20140142547A1 (en) | 2014-05-22 |
US20160324513A1 (en) | 2016-11-10 |
US8444671B2 (en) | 2013-05-21 |
US20110022081A1 (en) | 2011-01-27 |
WO2008079810A2 (en) | 2008-07-03 |
US10130347B2 (en) | 2018-11-20 |
WO2008079810A3 (en) | 2008-08-21 |
US9427221B2 (en) | 2016-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10130347B2 (en) | Hemostasis-enhancing device and method for its use | |
US9017374B2 (en) | Device and method for sealing blood vessels | |
US10624656B2 (en) | Apparatus and methods for treating obstructions within body lumens | |
US10441755B2 (en) | Catheter with vessel lining and methods for using same | |
EP1703845B1 (en) | Apparatus for delivering haemostatic sealing materials | |
US7789893B2 (en) | Method and apparatus for promoting hemostasis of a blood vessel puncture | |
KR100818903B1 (en) | Medical device with braid and coil | |
EP1748733B1 (en) | Self-tensioning vascular occlusion device | |
US6183443B1 (en) | Expandable introducer sheath | |
US20050245876A1 (en) | Apparatus and methods for facilitating access through a puncture including sealing compound therein | |
US20080004569A1 (en) | Expandable Introducer Sheath to Preserve Guidewire Access | |
US20100198159A1 (en) | Expandable introducer sheath to preserve guidewire access | |
US20170135725A1 (en) | Collapsible sheath and tapered dilator for tissue puncture access | |
US10952710B2 (en) | Balloon closure device | |
US9326790B2 (en) | Catheter with vessel lining and methods for using same | |
JP6359086B2 (en) | Vascular closure device and method for positioning a vascular closure device | |
EP2624880A1 (en) | Catheter with vessel lining and methods for using same | |
EP2979722A2 (en) | Catheter with vessel lining and methods for using same | |
US20210204925A1 (en) | Balloon closure device | |
US20120330352A1 (en) | Transapical closure devices and methods for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CARDIVA MEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:YASSINZADEH, ZIA;REEL/FRAME:019023/0791 Effective date: 20070102 |
|
AS | Assignment |
Owner name: COMERICA BANK, A TEXAS BANKING ASSOCIATION,MICHIGA Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIVA MEDICAL, INC.;REEL/FRAME:024329/0775 Effective date: 20100405 Owner name: COMERICA BANK, A TEXAS BANKING ASSOCIATION, MICHIG Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIVA MEDICAL, INC.;REEL/FRAME:024329/0775 Effective date: 20100405 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: CARDIVA MEDICAL, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:COMERICA BANK;REEL/FRAME:033531/0892 Effective date: 20140805 |